Asked by: Christine Jardine (Liberal Democrat - Edinburgh West)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, if he will make an estimate of the total number staff days lost to long term sick absences in each Department in each year since 2021.
Answered by John Glen - Paymaster General and Minister for the Cabinet Office
Cabinet Office publishes sickness absence data for the Civil Service on an annual basis on gov.uk. Our preferred measure is Average Working Days Lost (AWDL) per staff year which accounts for workforce size and composition. The table below provides the data requested, days lost per department, along with AWDL for context. Data for 2023 are in production for planned publication by end March 2024.
Table: Long Term Sickness Absence by Department 2021 and 2022
Organisation | 2021 | 2022 | ||
|---|---|---|---|---|
Days | AWDL | Days | AWDL | |
Attorney General's Departments | 5,250 | 2.2 | 7,190 | 2.9 |
Crown Prosecution Service | 18,530 | 3.1 | 23,570 | 3.7 |
Serious Fraud Office | 830 | 1.8 | 940 | 2.0 |
Business, Energy and Industrial Strategy | 34,010 | 2.1 | 47,160 | 2.5 |
Cabinet Office | 13,090 | 1.4 | 20,750 | 1.9 |
National Savings and Investments | 370 | 1.9 | 170 | 0.9 |
Charity Commission | 1,300 | 2.7 | s | s |
Department for Levelling Up, Housing and Communities | 6,850 | 2.0 | 7,670 | 2.0 |
Competition and Markets Authority | 1,100 | 1.4 | 870 | 1.0 |
Department for Digital, Culture Media and Sport | 2,670 | 1.3 | 4,110 | 1.4 |
Ministry of Defence | 219,380 | 4.1 | 149,690 | 2.8 |
Department for International Trade | 3,960 | 0.8 | 6,820 | 1.3 |
Department for Education | 9,580 | 1.3 | 20,410 | 2.6 |
Department for Environment Food and Rural Affairs | 19,210 | 1.9 | 27,070 | 2.4 |
ESTYN | 410 | 3.9 | 320 | 3.1 |
Foreign, Commonwealth and Development Office | 16,750 | 1.9 | 18,830 | 2.3 |
Food Standards Agency | 3,850 | 2.9 | 4,500 | 3.4 |
The Health and Safety Executive | 7,440 | 3.2 | 10,520 | 4.2 |
Department of Health and Social Care | 20,880 | 2.2 | 27,770 | 2.6 |
HM Revenue and Customs | 189,360 | 3.2 | 243,040 | 3.9 |
HM Treasury | 2,770 | 1.1 | 3,990 | 1.5 |
Home Office | 109,360 | 3.4 | 148,080 | 4.5 |
Ministry of Justice | 435,690 | 6.0 | 596,420 | 7.4 |
National Crime Agency | 10,640 | 2.1 | 15,180 | 3.3 |
Northern Ireland Office | 140 | 0.9 | 420 | 2.4 |
Office for Standards in Education, Children's Services & Skills | 6,530 | 3.6 | 9,270 | 5.3 |
Office of Gas and Electricity Markets | 2,260 | 2.1 | 2,650 | 2.1 |
Office of Rail and Road | 590 | 1.9 | 290 | 0.9 |
Scotland Office (incl. Office Advocate General for Scotland) | 320 | 2.8 | 490 | 4.2 |
Scottish Government | 111,300 | 5.4 | 134,510 | 5.9 |
Department for Transport | 51,950 | 3.6 | 71,260 | 4.9 |
United Kingdom Statistics Authority | 9,250 | 2.4 | 10,070 | 2.2 |
UK Export Finance | 250 | 0.7 | 340 | 0.8 |
UK Supreme Court | * | * | 280 | 5.2 |
Wales Office | 230 | 4.4 | 190 | 4.1 |
Water Services Regulation Authority | 570 | 2.4 | 250 | 1.0 |
Welsh Government | 14,590 | 2.8 | 20,110 | 3.7 |
Department for Work and Pensions | 243,230 | 3.3 | 383,320 | 4.5 |
Notes:
Annual Data for year ending 31 March 2021 and 31 March 2022
Source – Management Information
Days rounded to nearest 10 days, AWDL rounded to 1 decimal place
s = suppressed due to data review, * = suppressed due to low counts
For sickness absence publications see https://www.gov.uk/government/collections/sickness-absence
Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the cost to the NHS of unused personal protective equipment during the covid-19 pandemic; what steps her Department is taking to reclaim those costs; and how much has been reclaimed as of 29 November 2023.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In the face of an unprecedented global pandemic, we had to rapidly increase the volume of personal protective equipment (PPE) and change how we bought it in order to protect the National Health Service, including frontline health and care workers, and save lives. The Department’s most recent published annual report and accounts have already disclosed the cost of providing PPE during the pandemic, and are available at the following link:
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make tackling loneliness and social isolation a public health priority.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We recognise that loneliness and social isolation can affect many people and impact on their health and wellbeing. In October 2018 the Department of Culture, Media and Sport published the world’s first ever cross-government strategy to tackle loneliness ‘A connected society: a strategy for tackling loneliness’.
Social prescribing is a key component of the National Health Service’s Universal Personalised Care and can work well for those who are lonely or socially isolated. Social Prescribing link workers take a holistic approach to people’s health and wellbeing. They connect people to community groups and statutory services for practical and emotional support. Social prescribing can work well for those who are socially isolated. Social prescribing activities are commissioned locally, utilising community assets often in the Voluntary, Community and Social Enterprise sector.
Asked by: Martyn Day (Scottish National Party - Linlithgow and East Falkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department has taken to ensure that second generation GLP-1 weight management medications are being (a) sold and (b) marketed according to their licence specifications.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department and the Medicines and Healthcare products Regulatory Agency (MHRA) are members of the GLP1-RA Incident Management Team. Risk management in relation to the advertising and sale of these medicinal products is a standing item for discussion.
MHRA is obliged to consider complaints received about the advertisement of prescription-only medicines (POMs) to the public. Advertising investigations are carried out on a case-by-case basis, having regard to the circumstances of the particular case. Completed advertising investigations leading to correction of advertising materials are available at the following link:
https://www.gov.uk/government/collections/advertising-investigations-by-mhra
MHRA works closely with other regulators to help ensure that the public are protected from the advertising of POMs. A joint enforcement operation is in place with the Advertising Standards Authority to take targeted action against weight-loss treatment providers who use social media to promote POMs.
MHRA takes proportionate action, on a case-by-case basis, to enforce the Human Medicines Regulations 2012 in respect of the advertisement, sale, and supply of second-generation glucagon-like peptide 1 weight management medications. In cases of serious non-compliance, this can include undertaking formal criminal investigations and, where appropriate and evidentially supported, prosecution through the Crown Prosecution Service.
Asked by: Martyn Day (Scottish National Party - Linlithgow and East Falkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department has held discussions with the MHRA on preventing unlicensed online (a) marketing and (b) sale of second generation GLP-1 weight management medications.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department and the Medicines and Healthcare products Regulatory Agency (MHRA) are members of the GLP1-RA Incident Management Team. Risk management in relation to the advertising and sale of these medicinal products is a standing item for discussion.
MHRA is obliged to consider complaints received about the advertisement of prescription-only medicines (POMs) to the public. Advertising investigations are carried out on a case-by-case basis, having regard to the circumstances of the particular case. Completed advertising investigations leading to correction of advertising materials are available at the following link:
https://www.gov.uk/government/collections/advertising-investigations-by-mhra
MHRA works closely with other regulators to help ensure that the public are protected from the advertising of POMs. A joint enforcement operation is in place with the Advertising Standards Authority to take targeted action against weight-loss treatment providers who use social media to promote POMs.
MHRA takes proportionate action, on a case-by-case basis, to enforce the Human Medicines Regulations 2012 in respect of the advertisement, sale, and supply of second-generation glucagon-like peptide 1 weight management medications. In cases of serious non-compliance, this can include undertaking formal criminal investigations and, where appropriate and evidentially supported, prosecution through the Crown Prosecution Service.
Asked by: Emma Hardy (Labour - Kingston upon Hull West and Hessle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to implement the recommendations in the report Continuing to pay the price: the impact of prescription charges on people with long-term conditions, published by the Prescription Charges Coalition in March 2023.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
No decision has been made on whether to make any changes to prescription charges for 2024/2025. Responsibility for prescribing, including the duration of prescriptions, rests with the doctor who has clinical responsibility for that aspect of a patient's care. The Department has no plans to give prescribers directives on this. It also has no plans to conduct such a review of the list of conditions that entitle a patient to apply for a medical exemption certificate.
This Government is committed to tackling cost of living pressures; and has decided that the prescription charge upper age exemption will remain at 60, meaning that it will not change to align to State Pension Age. The decision was published in June 2023, and more information is available at the following link:
https://www.gov.uk/government/news/free-prescription-age-frozen-at-60
Information on the prescription exemptions is promoted to professionals and patients to ensure they are aware of a patient’s entitlement. The NHS Business Services Authority also undertakes activities such as continuous social media promotion, paid social media advertising, provision of online resources for healthcare professionals to download and use in general practitioner surgeries and pharmacies, for example, posters and leaflets, media releases to news titles and promotion through healthcare bulletins.
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to promote the uptake of Covid-19 booster vaccinations.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Throughout autumn and winter, the Government and the National Health Service are encouraging those that are eligible to take up the Influenza (flu) and COVID-19 vaccination offer. A range of communications are in place to ensure those eligible are aware of the offer. This includes:
- NHS England’s national call/recall programme which coordinates mail and text message prompts to those eligible; in addition to communications from general practices and pharmacies;
- an extensive public information, media and external affairs communications programme;
- a paid Winter Vaccinations campaign ‘Get vaccinated. Get winter strong’, which launched on 1 November 2023 and is running up to 17 December 2023 across a range of broadcast and digital channels supported by audience tailored activity;
- a health and social care workforce communications programme; and
- provision by NHS England of financial arrangements to encourage providers to accelerate take up of both vaccines.
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to promote the uptake of influenza vaccinations.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Throughout autumn and winter, the Government and the National Health Service are encouraging those that are eligible to take up the Influenza (flu) and COVID-19 vaccination offer. A range of communications are in place to ensure those eligible are aware of the offer. This includes:
- NHS England’s national call/recall programme which coordinates mail and text message prompts to those eligible; in addition to communications from general practices and pharmacies;
- an extensive public information, media and external affairs communications programme;
- a paid Winter Vaccinations campaign ‘Get vaccinated. Get winter strong’, which launched on 1 November 2023 and is running up to 17 December 2023 across a range of broadcast and digital channels supported by audience tailored activity;
- a health and social care workforce communications programme; and
- provision by NHS England of financial arrangements to encourage providers to accelerate take up of both vaccines.
Asked by: Martyn Day (Scottish National Party - Linlithgow and East Falkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to prevent second generation GLP-1 weight management medications being available for purchase online without prescription.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) enforces the Human Medicines Regulations 2012 on behalf of the Secretary of State for Health and Social Care. Buying any medicinal product, including second generation glucagon-like peptide 1 weight management medications, from illegally trading online suppliers significantly increases the risk of getting a product which is either falsified or not licensed for use in the United Kingdom. The MHRA continues to work with social media and online sales platforms to build strong partnerships to identify and quickly remove illegal medicines from sale and to identify those unlawfully trading in medicines. We work with partners to remove web content where we can, and to block harmful URLs and domain names.
The MHRA works to prevent false customer feedback from promoting illegal online suppliers and has arrangements in place with major search engine providers to delist offending domain names. The MHRA also works with payment providers to disrupt the processing of payments via illegal sites. The MHRA will take appropriate enforcement action, including, where necessary, prosecuting those who put public health at risk.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that health and care information is provided in an accessible format.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
National Health Service organisations and publicly funded social care providers must comply with the Accessible Information Standard (AIS) to meet the communication needs of patients and carers with a disability, impairment, or sensory loss. NHS England has completed a review of the AIS to help ensure that everyone’s communication needs are met in health and care provision. The review considered the effectiveness of the current AIS, how the standard is implemented and enforced in practice, and identified recommendations for improvement. The revised standard will be published in due course.
Following publication of the revised standard, NHS England will continue work to support implementation with awareness raising, communication and engagement and updated e-learning modules on the AIS to ensure NHS staff are better aware of the standard and their roles and responsibilities in implementing it.
These actions should support better and more consistent implementation of the standard.
In addition to the AIS, following Royal Assent of the British Sign Language Act 2022, the Government Communication Service will promote and facilitate the use of British Sign Language (BSL) in communications with the public. This is expected to support BSL users to access public services, including health and care services. Our work to promote BSL builds on a longstanding departmental commitment to ensuring our content is accessible for disabled audiences. Our GOV.UK and social media content closely follows guidance from the Government Digital Service. All videos are captioned for those who are hard of hearing, graphics have accessible texts and colours for those with reading difficulties and have voiceover descriptions for the partially sighted.